HOME >> MEDICINE >> NEWS
There's more than meets the eye in judging the size of an object

Neuroscientists from the University of Washington and the University of Minnesota have found that the first area in the cortex of the human brain that receives information from the eyes processes the perceived size, rather than the actual size, of an object.

"Our eyes only tell us part of what we need to be able to see. The other part is done by the brain, taking the input from the eyes and making guesses or inferences about what's out there in the enviro You can't always trust your eyes. nment. Usually these inferences are very accurate, but sometimes they lead us astray in the form of visual illusions," said Scott Murray, a UW assistant psychology professor and lead author of a study published in the current issue of Nature Neuroscience.

Murray and his Minnesota colleagues, Huseyin Boyaci and Daniel Kersten, used functional magnetic resonance imaging (fMRI) to see how the brain processes the size of objects when faced with an illusion such as the long-known moon illusion. For centuries it has been known that the moon, while rising, looks huge when it is near the horizon and smaller when high in the sky. It is in reality always the same size.

The researchers used a similar illusion, one that looked at the perceived difference in the size of an object at different distances. For their experiment they placed two identical spheres decorated with a checkerboard pattern in the front and rear of a receding brick hallway. In this kind of illusion, the more distant object appears to occupy a larger portion of the visual field.

Using fMRI, the researchers examined how the brains of five people with normal vision registered this difference in perceived size.

They found that the brain region known as the primary visual cortex, which is the first area in the cortex to receive input from the retina, showed a difference. Even though both spheres occupied exactly the same size on the retina, the rear sphere activated an approximat
'"/>

Contact: Joel Schwarz
joels@u.washington.edu
206-543-2580
University of Washington
8-Mar-2006


Page: 1 2

Related medicine news :

1. Theres no modern substitute for some old-fashioned one-on-one
2. Theres more than meets the eye to catching a fly ball in the outfield
3. Fluoridated beverage consumption and dental fluorosis: Theres a connection
4. Stroke drug still meets resistance from doctors wary of its risks
5. New objective criteria improve PET scan reliability in detecting breast cancer metastasis
6. Educating health care professionals to prescribe drugs objectively
7. Reducing oral health disparities: Achieving healthy people 2010 objectives
8. Conscientious objection in medicine should not be tolerated

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: There more than meets the eye judging the size object

(Date:4/23/2014)... "simple and accessible detection methods that can rapidly ... of a single cell inside that population has ... Chang Lu. , In the Royal Society of ... announced that he and his coworkers have developed ... of a protein ( Chem. Sci. , 2014, ...
(Date:4/23/2014)... are often displayed in the popular Swedish children,s ... of high-sugar foods. A new study from the ... in children,s TV programmes as well as the ... and weight status. , Steingerdur Olafsdottir,s doctoral thesis ... popular Swedish children,s TV show Bolibompa. Healthy foods ...
(Date:4/23/2014)... led by a researcher from the Cancer Science Institute ... Singapore has identified the cancer specific stem cell which ... of developing new drugs for the treatment of this ... group, led by Dr Chan Shing Leng, Research Assistant ... that a cancer-specific variant of a cell surface protein, ...
(Date:4/23/2014)... in the journal Oncotarget , explored tumour ... or their own DNA signatures within the same ... design effective, targeted treatment strategies. , Firstly they ... and either the KRAS or BRAF mutation. Secondly, ... EGFR gene mutation have that specific mutation present ...
(Date:4/23/2014)... Alzheimer,s disease has been a rapidly evolving pursuit ... latest crook in the research road, scientists have ... proteins associated with the disease. The report, which ... , could have important implications for developing novel ... colleagues explain that for years, research has suggested ...
Breaking Medicine News(10 mins):Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:High-calorie and low-nutrient foods in kids' TV 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3Health News:Non-uniform genetic mutations identified in lung cancers could lead to targeted treatment 2
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Forecast and Market Analysis to 2022 ... Atopic Dermatitis - India Drug Forecast and ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a ... needs of severely obese patients, today announced initial ... a selective inhibitor of methionine aminopeptidase 2 (MetAP2), ... form of genetic obesity.  These results showed improvements ...
(Date:1/14/2014)... InformEx, North America,s leading business partnering ... the 30 th edition of its annual conference at ... January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... and specialty chemical companies will take part in the conference, ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Cached News: